|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q2 FY2019
As of Mar 31, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Prepaid insurance | ||||||||||||||||||||
| Other prepaid expenses and current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| EQUIPMENT, net | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Investment | ||||||||||||||||||||
| Long-term prepaid insurance | ||||||||||||||||||||
| Right-of-use asset, operating lease asset | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Insurance note payable | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term operating lease liability | ||||||||||||||||||||
| Long-term finance lease liability | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of September 30, 2023 and December 31, 2022 | ||||||||||||||||||||
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 3,729,206 and 1,657,768 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
